Benzinga's Top Initiations By: Benzinga via Benzinga March 10, 2014 at 08:41 AM EDT Analysts at UBS initiated coverage on shares of Concert Pharmaceuticals (NASDAQ: CNCE) with a “buy” rating. The target price for Concert ... Read More >> Related Stocks: Biocryst Pharma Inc Concert Pharmaceutic Eagle Pharmaceuticals Installed Building Products